No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs367681743 |
chr2:34045807-34045808 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs111696894 |
chr2:34045821-34045822 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs373637634 |
chr2:34045822-34045823 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs368094166 |
chr2:34045848-34045849 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs6543769 |
chr2:34045896-34045897 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
6 |
rs567670797 |
chr2:34045973-34045974 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs139899031 |
chr2:34045983-34045984 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs6543770 |
chr2:34046012-34046013 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
9 |
rs572522826 |
chr2:34046013-34046014 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs112628027 |
chr2:34046049-34046050 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs535131624 |
chr2:34046072-34046073 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs368421662 |
chr2:34046079-34046080 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs72862995 |
chr2:34046089-34046090 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs531540970 |
chr2:34046123-34046124 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs543009693 |
chr2:34046124-34046125 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs538290754 |
chr2:34046177-34046178 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs577363267 |
chr2:34046201-34046202 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs185179416 |
chr2:34046216-34046217 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs552827595 |
chr2:34046217-34046218 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs11884177 |
chr2:34046245-34046246 |
Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
21 |
rs528142680 |
chr2:34046248-34046249 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs547905904 |
chr2:34046254-34046255 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs561327494 |
chr2:34046309-34046310 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs189651812 |
chr2:34046366-34046367 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs557559278 |
chr2:34046394-34046395 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs145340790 |
chr2:34046400-34046401 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs181323718 |
chr2:34046414-34046415 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs186314806 |
chr2:34046437-34046438 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs79256336 |
chr2:34046445-34046446 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs566558535 |
chr2:34046539-34046540 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs191618895 |
chr2:34046548-34046549 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs535092959 |
chr2:34046554-34046555 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs142456231 |
chr2:34046584-34046585 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs13017284 |
chr2:34046688-34046689 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
35 |
rs370013656 |
chr2:34046690-34046691 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs183541717 |
chr2:34046692-34046693 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs111673855 |
chr2:34046721-34046722 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs577425988 |
chr2:34046780-34046781 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs546197767 |
chr2:34046795-34046796 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs559494580 |
chr2:34046833-34046834 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs188866633 |
chr2:34046845-34046846 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs192422748 |
chr2:34046884-34046885 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs561486018 |
chr2:34046934-34046935 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs530418684 |
chr2:34047016-34047017 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs550501240 |
chr2:34047021-34047022 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs183321622 |
chr2:34047067-34047068 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs77075221 |
chr2:34047097-34047098 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs546937910 |
chr2:34047106-34047107 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs13400794 |
chr2:34047126-34047127 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
50 |
rs17014116 |
chr2:34047156-34047157 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|